Alibaba Health Information Technology Limited (ALBBY)
USD 8.67
(0.0%)
USD 8.67
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 5.89 Billion CNY | 3.4% |
| 2023 | 5.89 Billion CNY | 38.79% |
| 2022 | 4.1 Billion CNY | 13.57% |
| 2021 | 3.61 Billion CNY | 62.11% |
| 2020 | 2.23 Billion CNY | 67.61% |
| 2019 | 1.33 Billion CNY | 103.92% |
| 2018 | 652.82 Million CNY | 248.65% |
| 2017 | 187.24 Million CNY | 392.84% |
| 2016 | 37.99 Million CNY | 137.84% |
| 2015 | 15.97 Million CNY | -56.85% |
| 2014 | 37.02 Million CNY | -35.24% |
| 2013 | 57.16 Million CNY | 28.13% |
| 2012 | 44.61 Million CNY | 40.02% |
| 2011 | 31.86 Million CNY | -4.31% |
| 2010 | 33.29 Million CNY | 183.98% |
| 2009 | 11.72 Million CNY | -73.77% |
| 2008 | 44.7 Million CNY | -30.35% |
| 2007 | 64.17 Million CNY | -66.27% |
| 2006 | 190.25 Million CNY | 75.65% |
| 2005 | 108.31 Million CNY | 276.45% |
| 2004 | 28.77 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 5.89 Billion CNY | 3.4% |
| 2024 Q2 | 402.09 Million USD | 0.0% |
| 2024 Q4 | 419.86 Million USD | 0.0% |
| 2023 Q2 | 341.6 Million USD | 0.0% |
| 2023 FY | 5.7 Billion CNY | 38.79% |
| 2023 Q4 | 487.26 Million USD | 0.0% |
| 2022 Q4 | 351.13 Million USD | 0.0% |
| 2022 FY | 4.1 Billion CNY | 13.57% |
| 2022 Q2 | 289.44 Million USD | 0.0% |
| 2021 Q2 | 265.67 Million USD | 0.0% |
| 2021 Q4 | 268.05 Million USD | 0.0% |
| 2021 FY | 3.61 Billion CNY | 62.11% |
| 2020 Q2 | 81.57 Million USD | 0.0% |
| 2020 FY | 2.23 Billion CNY | 67.61% |
| 2020 Q4 | 81.07 Million USD | 0.0% |
| 2019 FY | 1.33 Billion CNY | 103.92% |
| 2018 FY | 652.82 Million CNY | 248.65% |
| 2017 FY | 187.24 Million CNY | 392.84% |
| 2016 FY | 37.99 Million CNY | 137.84% |
| 2015 FY | 15.97 Million CNY | -56.85% |
| 2014 FY | 37.02 Million CNY | -35.24% |
| 2013 FY | 57.16 Million CNY | 28.13% |
| 2012 FY | 44.61 Million CNY | 40.02% |
| 2011 FY | 31.86 Million CNY | -4.31% |
| 2010 FY | 33.29 Million CNY | 183.98% |
| 2009 FY | 11.72 Million CNY | -73.77% |
| 2008 FY | 44.7 Million CNY | -30.35% |
| 2007 FY | 64.17 Million CNY | -66.27% |
| 2006 FY | 190.25 Million CNY | 75.65% |
| 2005 FY | 108.31 Million CNY | 276.45% |
| 2004 FY | 28.77 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | -4296.917% |
| Café Serendipity Holdings, Inc. | 1196.00 USD | -492919716.054% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 12.17 Million USD | -48325.835% |
| LIGAND PHARMACEUTICAL INC | 88.02 Million USD | -6597.25% |
| MedGen, Inc. | 1.05 USD | -561459142757.143% |
| Omni Health, Inc. | 1.55 Million USD | -379620.304% |
| Oxford Investments Holdings Inc. | 31.45 Thousand USD | -18740191.818% |
| Pineapple, Inc. | -1.02 Million USD | 575426.147% |
| ScripsAmerica, Inc. | 27.59 Million USD | -21262.112% |